Medical Education Library

Advances in Transdermal Estrogen-Only Therapy for Vasomotor Symptoms

This resource is sponsored by Noven Therapeutics, LLC and was reviewed prior to publication.
Author and Disclosure Information

 

What are the key challenges for clinician providers who care for the older woman past reproductive age or those who are surgically menopausal? Menopausal symptoms are a concern for a substantial number of women in the United States. Annually, 11 million women reach the age of natural menopause—approximately 51.3 years.1,2 In addition, more than 500,000 women undergo a hysterectomy each year, with removal of the ovaries in more than 50%.3 Whether menopause occurs naturally or is surgically-induced, more than 85% of these women experience symptoms associated with estrogen deficiency, including, but not limited to, hot flushes and night sweats.4,5

Recommended Reading

BMN 673 monotherapy makes splash in BRCA-mutated ovarian, breast cancer
MDedge ObGyn
The new anterior repair
MDedge ObGyn
Tumor distance from nipple boosts nomogram results
MDedge ObGyn
Pertuzumab approved as first neoadjuvant treatment for breast cancer
MDedge ObGyn
Sebelius: Shutdown, sequester bad for medical research
MDedge ObGyn
Federal shutdown begins; health programs impacted
MDedge ObGyn
Obamacare exchanges open for enrollment during shutdown
MDedge ObGyn
No weight gain or sexual dysfunction with first nonhormonal treatment for hot flashes
MDedge ObGyn
New option for treating menopausal vasomotor symptoms receives FDA approval
MDedge ObGyn
Ospemifene for dyspareunia in postmenopausal women is well tolerated
MDedge ObGyn